Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. I. Identification of the metabolites of BCP in human urine.
D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000652:urine*; D002247:Carbon Isotopes; D002849:Chromatography, Gas; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003510:Cyclohexanes / Q000378:metabolism / Q000652:urine; D005965:Glucuronates / Q000652:urine; D006801:Humans; D007259:Infrared Rays; D011743:Pyrimidines / Q000378:metabolism / Q000652:urine*; D013053:Spectrophotometry; D013431:Sulfates / Q000652:urine; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D002247:Carbon Isotopes; D003510:Cyclohexanes; D005965:Glucuronates; D011743:Pyrimidines; D013431:Sulfates